Rankings
▼
Calendar
IDXX Q4 2025 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena
IDXX
IDEXX Laboratories, Inc.
$48B
Q4 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$1.1B
+14.3% YoY
Gross Profit
$658M
60.3% margin
Operating Income
$316M
28.9% margin
Net Income
$248M
22.8% margin
EPS (Diluted)
$3.08
QoQ Revenue Growth
-1.3%
Cash Flow
Operating Cash Flow
$352M
Free Cash Flow
$323M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$3.4B
Total Liabilities
$1.7B
Stockholders' Equity
$1.6B
Cash & Equivalents
$180M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$954M
+14.3%
Gross Profit
$658M
$571M
+15.3%
Operating Income
$316M
$262M
+20.6%
Net Income
$248M
$216M
+14.8%
Revenue Segments
Product
$652M
60%
Service
$438M
40%
Geographic Segments
UNITED STATES
$675M
61%
EMEA
$254M
23%
Asia Pacific
$94M
8%
Latin America
$45M
4%
CANADA
$42M
4%
← FY 2025
All Quarters